Screener
West Pharmaceutical Services WST Free cash flow margin
Free cash flow margin at other companies
Other financials
Where this comes from
Calculated from West Pharmaceutical Services’s reported figures.
Based on trailing twelve months.
The source filing: West Pharmaceutical Services’s 10-Q, filed July 23, 2026. Open the filing →
- Filed
- Jul 23, 2026, 4:15 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0000105770-26-000099
FAQ
- What is West Pharmaceutical Services's free cash flow margin?
- West Pharmaceutical Services (WST) reported free cash flow margin of 13.1% in Q2 2026.
- How has West Pharmaceutical Services's free cash flow margin changed year-over-year?
- West Pharmaceutical Services's free cash flow margin increased by 13.0% year-over-year, from 11.6% to 13.1%.
- What is the long-term trend for West Pharmaceutical Services's free cash flow margin?
- Over 5 years (2020 to 2025), West Pharmaceutical Services's free cash flow margin has grown at a 1.9% compound annual growth rate (CAGR), from 13.9% to 15.3%.
- What does free cash flow margin mean?
- Free cash flow (operating cash flow minus capital expenditures) as a percentage of revenue, trailing twelve months. Measures how efficiently revenue converts into discretionary cash.
Ask your AI about West Pharmaceutical Services's free cash flow margin.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude